You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

oxaliplatin

Showing 1 - 25 of 921
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunotherapy Gastrict Cancer Trial (Tislelizumab, apatinib, oxaliplatin)

Not yet recruiting
  • Immunotherapy Gastrict Cancer
  • (no location specified)
Jan 17, 2023

Advanced Gastric Carcinoma Trial in Dhaka (Trastuzumab, Oxaliplatin, Capecitabine)

Completed
  • Advanced Gastric Carcinoma
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
Aug 15, 2023

Gastric Cancer Trial in Beijing (Apatinib, Oxaliplatin, S1)

Recruiting
  • Gastric Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023

Immunotherapy, Gastrict Cancer Trial in Fuzhou (Tislelizumab, Apatinib Mesylate, oxaliplatin)

Recruiting
  • Immunotherapy
  • Gastrict Cancer
  • Fuzhou, China
    Fujian cancer hospital
Jan 17, 2023

Malignant Digestive System Tumor Trial in Atlanta (Fluorouracil, Leucovorin, Oxaliplatin)

Recruiting
  • Malignant Digestive System Neoplasm
  • Atlanta, Georgia
  • +2 more
Dec 12, 2022

Gastric Cancer Stage IV Trial (Oxaliplatin, Levo-Leucovorin, 5-fluorouracil)

Not yet recruiting
  • Gastric Cancer Stage IV
  • Oxaliplatin
  • +5 more
  • (no location specified)
Nov 13, 2022

Biliary Cancer, Bile Duct Cancer, Cancer of the Bile Duct Trial run by the National Cancer Institute (NCI) (oxaliplatin,

Not yet recruiting
  • Biliary Cancer
  • +2 more
  • oxaliplatin
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
May 13, 2023

Stage III Colon Cancer Trial in France (Oxaliplatin, Oxaliplatin LBM)

Active, not recruiting
  • Stage III Colon Cancer
  • Oxaliplatin
  • Oxaliplatin LBM
  • Marseille, Bouches Du Rhône, France
  • +10 more
Aug 2, 2022

Gastric Cancer Trial in Beijing (S-1, Trastuzumab, Oxaliplatin)

Completed
  • Gastric Cancer
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences
Aug 14, 2022

Elderly Metastatic Colorectal Cancer Patients Trial in Padua (Capecitabine, Oxaliplatin, Bevacizumab)

Active, not recruiting
  • Elderly Metastatic Colorectal Cancer Patients
  • Padua, Italy
    Istituto Oncologico Veneto IRCCS
Mar 30, 2022

Colorectal Cancer Trial in Frankfurt, Zurich (Oxaliplatin, 5-Fluorouracil, Leucovorin)

Completed
Has Results
  • Colorectal Cancer
  • Oxaliplatin
  • +3 more
  • Frankfurt, Germany
  • +1 more
Oct 3, 2022

Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo

Not yet recruiting
  • Colorectal Adenocarcinoma
  • +2 more
  • Trondheim, Trondelag, Norway
  • +2 more
Aug 15, 2022

Gastric Cancer Trial in Gyeonggi-do (Oxaliplatin, Capecitabine)

Recruiting
  • Gastric Cancer
  • Gyeonggi-do, Korea, Republic of
    Hallym University Medical Center
Feb 4, 2022

Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)

Recruiting
  • Gastric Cancer
  • +10 more
  • Kyiv, Ukraine
    National Cancer Institute
Aug 31, 2023

Gastric Cancer Trial in Mykolaiv (Docetaxel, Oxaliplatin, Leucovorin)

Active, not recruiting
  • Gastric Cancer
  • Mykolaiv, Ukraine
    Ukrainian Society of Clinical Oncology
Apr 11, 2022

Neuroblastoma Trial in United States (Tolcapone, Oxaliplatin)

Terminated
  • Neuroblastoma
  • Little Rock, Arkansas
  • +8 more
Aug 23, 2022

Digestive Cancer Trial in Pierre-Bénite, Saint-Herblain, Saint-Mandé (5-Fluorouracil, L-Folinic acid, Oxaliplatin)

Terminated
  • Digestive Cancer
  • Pierre-Bénite, France
  • +2 more
Apr 19, 2022

Hepatocellular Carcinoma Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)

Recruiting
  • Hepatocellular Carcinoma Resectable
  • Oxaliplatin
  • +5 more
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Mar 1, 2023

Colorectal Tumors Trial in Philadelphia (bevacizumab, cetuximab, Oxaliplatin)

Terminated
Has Results
  • Colorectal Neoplasms
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Dec 30, 2021

Colonic Tumors, Neoadjuvant Therapy, Immune Checkpoint Inhibitors Trial in Nanning (Tislelizumab, Oxaliplatin, Capecitabine)

Recruiting
  • Colonic Neoplasms
  • +2 more
  • Nanning, Guangxi, China
    The First Affiliated Hospital of Guangxi Medical University
Nov 9, 2023

Gastric Cancer Trial in Jinan (SHR1210, Apatinib, S1)

Recruiting
  • Gastric Cancer
  • Jinan, Shandong, China
    Qilu hospital of Shandong univertisy
Mar 30, 2022

Biliary Tract Tumor Trial in Nanjing (Tislelizumab, Lenvatinib, Oxaliplatin)

Recruiting
  • Biliary Tract Tumor
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
Mar 14, 2022

Liver, Cancer of, Primary Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)

Recruiting
  • Liver, Cancer of, Primary Resectable
  • Oxaliplatin
  • +5 more
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Jan 18, 2023

Liver Cancer Trial in France (Oxaliplatin, Irofulven)

Completed
  • Liver Cancer
  • Bordeaux, France
  • +6 more
Nov 24, 2021

Phase II, Open-label, Parallel 2-arm, Multi-center Trial in Kaohsiung, Taichung, Tainan (Gemcitabine 1000 mg, Nab paclitaxel,

Recruiting
  • Phase II, Open-label, Parallel 2-arm, Multi-center
  • Gemcitabine 1000 mg
  • +4 more
  • Kaohsiung, Taiwan
  • +2 more
Jun 12, 2022